PPCB — Propanc Biopharma Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Propanc Biopharma Implements Reverse Stock Split To Support Continued Nasdaq Listing And Growth Plans
Brief: Propanc Biopharma Inc - Files To Offer Resale Of Up To 15 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Propanc Biopharma’S Lead Asset Prp Shows >85% Tumor Growth Inhibition In Preclinical Pancreatic Models
Brief: Propanc Biopharma Files Prospectus For Resale Of 2 Million Shares By Selling Stockholder - SEC Filing
Brief: Propanc Biopharma Provides Corporate Update And Reports First Quarter 2025/26 Results
Brief: Propanc Biopharma Pursues Strategic Acquisition of DAT Firms Trading Below Market Cap To Net Asset Value
Brief: Propanc Biopharma Announces Strategic Financing Agreement Of Up To $100 Million With Hexstone Capital
Brief: Propanc Biopharma Announces Plan To Acquire $100 Million Of Ethereum
Brief: Propanc Biopharma Provides Shareholder Update
Brief: Propanc Biopharma Announces Nasdaq Uplisting And Pricing Of $4 Million Public Offering
Brief: Propanc Biopharma Updates On Preparation Of PRP And Its Recently Completed Reverse Stock Split
Brief: Propanc Biopharma submits orphan drug designation request to FDA for treatment of ovarian cancer
Brief: Propanc Biopharma prepares orphan drug application for ovarian cancer drug